Data from the CCC19 registry were evaluated to uncover risk factors associated with increased 30-day mortality in patients with cancer infected with COVID-19.
In a study of men with mCRPC receiving chemotherapy and maximal androgen ablation, those who had an objective response to treatment had a significantly higher subcutaneous adipose tissue index than those who did not.
Castration-resistant prostate cancer correlates strongly with development of metastasis in men with PSA relapse following radical surgery for localized prostate cancer, but it occurs much sooner, and thus may provide an intermediate endpoint in clinical trials of new therapeutics.
Compared with sunitinib alone, nivolumab plus cabozantinib therapy was associated with a 49% decreased risk for progression and 40% decreased risk for death.
